Depression and atrial fibrillation in a reciprocal liaison: a neuro-cardiac link

References

• Ahn, H. J., Lee, S.-R., Choi, E.-K., Bae, N. Y., Ahn, H.-J., Kwon, S., Lee, S.-W., Han, K.-D., Oh, S., & Lip, G. Y. H. (2023). Increased risk of incident atrial fibrillation in young adults with mental disorders: a nationwide population-based study. Heart Rhythm, 20(3), 365–373. Online ahead of print. doi: 10.1016/j.hrthm.2022.12.019.
   PubMed Web of Science ®Google Scholar
• Ai, Y., Xing, Y., Yan, L., Ma, D., Gao, A., Xu, Q., Zhang, S., Mao, T., Pan, Q., Ma, X., & Zhang, J. (2022). Atrial fibrillation and depression: A bibliometric analysis from 2001 to 2021. Frontiers in Cardiovascular Medicine, 9, 775329. doi: 10.3389/fcvm.2022.775329.
   PubMed Web of Science ®Google Scholar
• Ali, A., Mostafa, W., Fernandez, C., Ahmad, H., & Htwe, N. (2020). Apathetic thyroid storm with cardiorespiratory failure, pulmonary embolism, and coagulopathy in a young male with graves’ disease and myopathy. Case Rep Endocrinol, 2020, 8896777.
   PubMed Web of Science ®Google Scholar
• Andreazza, A. C., Kauer-Sant’anna, M., Frey, B. N., Bond, D. J., Kapczinski, F., Young, L. T., & Yatham, L. N. (2008). Oxidative stress markers in bipolar disorder: A meta-analysis. Journal of Affective Disorders, 111(2-3), 135–144. doi: 10.1016/j.jad.2008.04.013.
   PubMed Web of Science ®Google Scholar
• Ariansen, I., Dammen, T., Abdelnoor, M., Tveit, A., & Gjesdal, K. (2011). Mental health and sleep in permanent atrial fibrillation patients from the general population. Clinical Cardiology, 34(5), 327–331. doi: 10.1002/clc.20883.
   PubMed Web of Science ®Google Scholar
• Aviles, R. J., Martin, D. O., Apperson-Hansen, C., Houghtaling, P. L., Rautaharju, P., Kronmal, R. A., Tracy, R. P., Van Wagoner, D. R., Psaty, B. M., Lauer, M. S., & Chung, M. K. (2003). Inflammation as a risk factor for atrial fibrillation. Circulation, 108(24), 3006–3010. doi: 10.1161/01.CIR.0000103131.70301.4F.
   PubMed Web of Science ®Google Scholar
• Baghai, T. C., Binder, E. B., Schule, C., Salyakina, D., Eser, D., Lucae, S., Zwanzger, P., Haberger, C., Zill, P., Ising, M., Deiml, T., Uhr, M., Illig, T., Wichmann, H.-E., Modell, S., Nothdurfter, C., Holsboer, F., Müller-Myhsok, B., Möller, H.-J., Rupprecht, R., & Bondy, B. (2006). Polymorphisms in the angiotensin-converting enzyme gene are associated with unipolar depression, ACE activity and hypercortisolism. Molecular Psychiatry, 11(11), 1003–1015. doi: 10.1038/sj.mp.4001884.
   PubMed Web of Science ®Google Scholar
• Bahramali, E., Firouzabadi, N., Yavarian, I., Shayesteh, M. R. H., Erfani, N., Shoushtari, A. A., & Asadpour, R. (2016). Influence of ACE gene on differential response to sertraline versus fluoxetine in patients with major depression: a randomized controlled trial. European Journal of Clinical Pharmacology, 72(9), 1059–1064. doi: 10.1007/s00228-016-2079-0.
   PubMed Web of Science ®Google Scholar
• Berk, M., Williams, L. J., Jacka, F. N., O’Neil, A., Pasco, J. A., Moylan, S., Allen, N. B., Stuart, A. L., Hayley, A. C., Byrne, M. L., & Maes, M. (2013). So depression is an inflammatory disease, but where does the inflammation come from? BMC Medicine, 11, 200. doi: 10.1186/1741-7015-11-200.
   PubMed Web of Science ®Google Scholar
• Bode, H., Ivens, B., Bschor, T., Schwarzer, G., Henssler, J., & Baethge, C. (2021). Association of hypothyroidism and clinical depression: A systematic review and meta-analysis. JAMA Psychiatry, 78(12), 1375–1383. doi: 10.1001/jamapsychiatry.2021.2506.
   PubMed Web of Science ®Google Scholar
• Bogner, H. R., Cary, M. S., Bruce, M. L., Reynolds, C. F., Mulsant, B., Have, T. T., & Alexopoulos, G. S. (2005). The role of medical comorbidity in outcome of major depression in primary care: The prospect study. The American Journal of Geriatric Psychiatry, 13(10), 861–868. doi: 10.1097/00019442-200510000-00005.
   PubMed Web of Science ®Google Scholar
• Bondy, B., Baghai, T. C., Minov, C., Schüle, C., Schwarz, M. J., Zwanzger, P., Rupprecht, R., & Möller, H. J. ü. (2003). Substance P serum levels are increased in major depression: preliminary results. Biological Psychiatry, 53(6), 538–542. doi: 10.1016/s0006-3223(02)01544-5.
   PubMed Web of Science ®Google Scholar
• Bové, K. B., Watt, T., Vogel, A., Hegedüs, L., Bjoerner, J. B., Groenvold, M., Bonnema, S. J., Rasmussen, Å. K., & Feldt-Rasmussen, U. (2014). Anxiety and depression are more prevalent in patients with graves’ disease than in patients with nodular goitre. European Thyroid Journal, 3(3), 173–178. doi: 10.1159/000365211.
   PubMedGoogle Scholar
• Buff, D. D., Brenner, R., Kirtane, S. S., & Gilboa, R. (1991). Dysrhythmia associated with fluoxetine treatment in an elderly patient with cardiac disease. J Clin Psychiatry, 52, 174–176.
   PubMed Web of Science ®Google Scholar
• Carney, R. M., Freedland, K. E., & Veith, R. C. (2005). Depression, the autonomic nervous system, and coronary heart disease. Psychosomatic Medicine, 67 Suppl 1, S29–S33. doi: 10.1097/01.psy.0000162254.61556.d5.
   PubMed Web of Science ®Google Scholar
• Catipović-Veselica, K., Galić, A., Jelić, K., Baraban-Glavas, V., Sarić, S., Prlić, N., & Catipović, B. (2007). Relation between major and minor depression and heart rate, heart-rate variability, and clinical characteristics of patients with acute coronary syndrome. Psychological Reports, 100(3 Pt 2), 1245–1254. doi: 10.2466/pr0.100.4.1245-1254.
   PubMed Web of Science ®Google Scholar
• Chithiramohan, T., Parekh, J. N., Kronenberg, G., Haunton, V. J., Minhas, J. S., Panerai, R. B., Robinson, T. G., Divall, P., Subramaniam, H., Mukaetova-Ladinska, E., & Beishon, L. (2022). Investigating the association between depression and cerebral haemodynamics-A systematic review and meta-analysis. Journal of Affective Disorders, 299, 144–158. doi: 10.1016/j.jad.2021.11.037.
   PubMed Web of Science ®Google Scholar
• Choi, J., Lee, K. N., Kim, Y. G., et al. (2020). Depression and risk of atrial fibrillation: a nationwide population-based study. Eur Heart J Suppl, 41, ehaa946.2852. doi: 10.1093/ehjci/ehaa946.2852.
   Google Scholar
• Chrissobolis, S., Luu, A. N., Waldschmidt, R. A., Yoakum, M. E., & D’Souza, M. S. (2020). Targeting the renin angiotensin system for the treatment of anxiety and depression. Pharmacology, Biochemistry, and Behavior, 199, 173063. doi: 10.1016/j.pbb.2020.173063.
   PubMed Web of Science ®Google Scholar
• Chung, M. K., Martin, D. O., Sprecher, D., Wazni, O., Kanderian, A., Carnes, C. A., Bauer, J. A., Tchou, P. J., Niebauer, M. J., Natale, A., & Van Wagoner, D. R. (2001). C-reactive protein elevation in patients with atrial arrhythmias: Inflammatory mechanisms and persistence of atrial fibrillation. Circulation, 104(24), 2886–2891. doi: 10.1161/hc4901.101760.
   PubMed Web of Science ®Google Scholar
• Costa, R., Fatourou, E., Hoppensteadt, D., Fareed, J., & Halaris, A. (2022). Cardiolipin antibody: A potential biomarker for depression. J Pers Med, 12(11), 1759. doi: 10.3390/jpm12111759.
   PubMed Web of Science ®Google Scholar
• Dąbrowski, R., Smolis-Bąk, E., Kowalik, I., Kazimierska, B., Wójcicka, M., & Szwed, H. (2010). Quality of life and depression in patients with different patterns of atrial fibrillation. Kardiologia Polska, 68(10), 1133–1139.
   PubMed Web of Science ®Google Scholar
• Diug, B., Evans, S., Lowthian, J., Maxwell, E., Dooley, M., Street, A., Wolfe, R., Cameron, P., & McNeil, J. (2011). The unrecognized psychosocial factors contributing to bleeding risk in warfarin therapy. Stroke, 42(10), 2866–2871. doi: 10.1161/STROKEAHA.111.615674.
   PubMed Web of Science ®Google Scholar
• Dobrev, D., Heijman, J., Hiram, R., Li, N., & Nattel, S. (2023). Inflammatory signalling in atrial cardiomyocytes: a novel unifying principle in atrial fibrillation pathophysiology. Nature Reviews. Cardiology, 20(3), 145–167. Online ahead of print. doi: 10.1038/s41569-022-00759-w.
   PubMed Web of Science ®Google Scholar
• Dossett, M. L., Needles, E. W., Donahue, Z., Gadenne, G., Macklin, E. A., Ruskin, J. N., & Denninger, J. W. (2021). A SMART approach to reducing paroxysmal atrial fibrillation symptoms: Results from a pilot randomized controlled trial. Heart Rhythm O2, 2(4), 326–332. doi: 10.1016/j.hroo.2021.06.003.
   PubMedGoogle Scholar
• Dowlati, Y., Herrmann, N., Swardfager, W., Liu, H., Sham, L., Reim, E. K., & Lanctôt, K. L. (2010). A meta-analysis of cytokines in major depression. Biological Psychiatry, 67(5), 446–457. doi: 10.1016/j.biopsych.2009.09.033.
   PubMed Web of Science ®Google Scholar
• Drerup, U. (1988). [Central nervous system side effects due to anti-arrhythmia therapy. Psychotic depression due to flecainide]. Deutsche medizinische Wochenschrift (1946), 113(10), 386–388. doi: 10.1055/s-2008-1067650.
   PubMed Web of Science ®Google Scholar
• Eller, T., Vasar, V., Shlik, J., & Maron, E. (2008). Pro-inflammatory cytokines and treatment response to escitalopram in major depressive disorder. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 32(2), 445–450. doi: 10.1016/j.pnpbp.2007.09.015.
   PubMed Web of Science ®Google Scholar
• Feng, T., Malmo, V., Laugsand, L. E., Strand, L. B., Gustad, L. T., Ellekjær, H., Loennechen, J. P., Mukamal, K., & Janszky, I. (2020). Symptoms of anxiety and depression and risk of atrial fibrillation-The HUNT study. International Journal of Cardiology, 306, 95–100. doi: 10.1016/j.ijcard.2019.11.107.
   PubMed Web of Science ®Google Scholar
• Fenger-Grøn, M., Vestergaard, C. H., Ribe, A. R., Johnsen, S. P., Frost, L., Sandbæk, A., & Davydow, D. S. (2021). Association between bipolar disorder or schizophrenia and oral anticoagulation use in danish adults with incident or prevalent atrial fibrillation. JAMA Network Open, 4(5), e2110096. doi: 10.1001/jamanetworkopen.2021.10096.
   PubMed Web of Science ®Google Scholar
• Fenger-Grøn, M., Vestergaard, M., Pedersen, H. S., Frost, L., Parner, E. T., Ribe, A. R., & Davydow, D. S. (2019). Depression, antidepressants, and the risk of non-valvular atrial fibrillation: A nationwide Danish matched cohort study. European Journal of Preventive Cardiology, 26(2), 187–195. doi: 10.1177/2047487318811184.
   PubMed Web of Science ®Google Scholar
• Fernandes, B. S., Steiner, J., Molendijk, M. L., Dodd, S., Nardin, P., Gonçalves, C.-A., Jacka, F., Köhler, C. A., Karmakar, C., Carvalho, A. F., & Berk, M. (2016). C-reactive protein concentrations across the mood spectrum in bipolar disorder: a systematic review and meta-analysis. The Lancet. Psychiatry, 3(12), 1147–1156. doi: 10.1016/S2215-0366(16)30370-4.
   PubMed Web of Science ®Google Scholar
• Fichtner, S., Deisenhofer, I., Kindsmüller, S., Dzijan-Horn, M., Tzeis, S., Reents, T., Wu, J., Luise Estner, H., Jilek, C., Ammar, S., Kathan, S., Hessling, G., & Ladwig, K.-H. (2012). Prospective assessment of short- and long-term quality of life after ablation for atrial fibrillation. Journal of Cardiovascular Electrophysiology, 23(2), 121–127. doi: 10.1111/j.1540-8167.2011.02165.x.
   PubMed Web of Science ®Google Scholar
• Finch, S. J., & van Zyl, L. T. (2006). Cardioversion of persistent atrial arrhythmia after treatment with venlafaxine in successful management of major depression and posttraumatic stress disorder. Psychosomatics, 47(6), 533–536. doi: 10.1176/appi.psy.47.6.533.
   PubMed Web of Science ®Google Scholar
• Firouzabadi, N., Farshadfar, P., Haghnegahdar, M., Alavi-Shoushtari, A., & Ghanbarinejad, V. (2022). Impact of ACE2 genetic variant on antidepressant efficacy of SSRIs. Acta Neuropsychiatrica, 34(1), 30–36. doi: 10.1017/neu.2021.32.
   PubMed Web of Science ®Google Scholar
• Fitton, R., Sweetman, J., Heseltine-Carp, W., & van der Feltz-Cornelis, C. (2022). Anti-inflammatory medications for the treatment of mental disorders: A scoping review. Brain, Behavior, & Immunity - Health, 26, 100518. doi: 10.1016/j.bbih.2022.100518.
   PubMedGoogle Scholar
• Foroughi, M., Medina Inojosa, J. R., Lopez-Jimenez, F., Saeidifard, F., Suarez, L., Stokin, G. B., Prieto, M. L., Rocca, W. A., Frye, M. A., & Morgan, R. J. (2022). Association of bipolar disorder with major Adverse cardiovascular events: A population-based historical cohort study. Psychosomatic Medicine, 84(1), 97–103. doi: 10.1097/PSY.0000000000001017.
   PubMed Web of Science ®Google Scholar
• Frasure-Smith, N., Lespérance, F., Habra, M., Talajic, M., Khairy, P., Dorian, P., & Roy, D. (2009). Elevated depression symptoms predict long-term cardiovascular mortality in patients with atrial fibrillation and heart failure. Circulation, 120(2), 134–140, 3p following 140. doi: 10.1161/CIRCULATIONAHA.109.851675.
   PubMed Web of Science ®Google Scholar
• Fu, Y., Feng, S., Xu, Y., Yang, Y., Chen, H., He, W., Zhu, W., Yin, K., Xue, Z., & Wei, B. (2022). Association of depression, antidepressants with atrial fibrillation risk: A systemic review and meta-analysis. Frontiers in Cardiovascular Medicine, 9, 897622. doi: 10.3389/fcvm.2022.897622.
   PubMed Web of Science ®Google Scholar
• Fu, Y., He, W., Ma, J., & Wei, B. (2020). Relationship between psychological factors and atrial fibrillation: A meta-analysis and systematic review. Medicine, 99(16), e19615. doi: 10.1097/MD.0000000000019615.
   PubMed Web of Science ®Google Scholar
• Galli, F., Borghi, L., Carugo, S., Cavicchioli, M., Faioni, E. M., Negroni, M. S., & Vegni, E. (2017). Atrial fibrillation and psychological factors: a systematic review. PeerJ., 5, e3537. doi: 10.7717/peerj.3537.
   PubMed Web of Science ®Google Scholar
• Garg, P. K., Claxton, J. S., Soliman, E. Z., Chen, L. Y., Lewis, T. T., Mosley, T., & Alonso, A. (2021). Associations of anger, vital exhaustion, anti-depressant use, and poor social ties with incident atrial fibrillation: The atherosclerosis risk in communities study. European Journal of Preventive Cardiology, 28(6), 633–640. doi: 10.1177/2047487319897163.
   PubMed Web of Science ®Google Scholar
• Garg, P. K., O’Neal, W. T., Diez-Roux, A. V., Alonso., Soliman, E. Z., & Heckbert, S. (2019). Negative Affect and Risk of Atrial Fibrillation: MESA. Journal of the American Heart Association., 8, e010603. doi: 10.1161/JAHA.118.010603.
   PubMed Web of Science ®Google Scholar
• Gasparini, A., Callegari, C., Lucca, G., Bellini, A., Caselli, I., & Ielmini, M. (2022). Inflammatory biomarker and response to antidepressant in major depressive disorder: A systematic review and meta-analysis. Psychopharmacology Bulletin., 52, 36–52.
   PubMedGoogle Scholar
• Gehi, A. K., Sears, S., Goli, N., Walker, T. J., Chung, E., Schwartz, J., Wood, K. A., Guise, K., & Mounsey, J. P. (2012). Psychopathology and symptoms of atrial fibrillation: implications for therapy. Journal of Cardiovascular Electrophysiology, 23(5), 473–478. doi: 10.1111/j.1540-8167.2011.02264.x.
   PubMed Web of Science ®Google Scholar
• Gerstman, B. B., Jolson, H. M., Bauer, M., Cho, P., Livingston, J. M., & Platt, R. (1996). The incidence of depression in new users of beta-blockers and selected antihypertensives. Journal of Clinical Epidemiology, 49(7), 809–815. doi: 10.1016/0895-4356(96)00017-0.
   PubMed Web of Science ®Google Scholar
• Gisi, B., Althouse, A. D., Mathier, A. S., Pusateri, A., Rollman, B. L., LaRosa, A., & Magnani, J. W. (2020). The unmeasured burden: contribution of depression and psychological stress to patient-reported outcomes in atrial fibrillation. International Journal of Cardiology, 302, 75–80. doi: 10.1016/j.ijcard.2019.12.004.
   PubMed Web of Science ®Google Scholar
• Graff, S., Fenger-Grøn, M., Christensen, B., Pedersen, H. S., Christensen, J., Li, J., & Vestergaard, M. (2016). Long-term risk of atrial fibrillation after the death of a partner. Open Heart, 3(1), e000367. doi: 10.1136/openhrt-2015-000367.
   PubMedGoogle Scholar
• Guo, Y., Lip, G. Y., & Apostolakis, S. (2012). Inflammation in atrial fibrillation. Journal of the American College of Cardiology, 60(22), 2263–2270. doi: 10.1016/j.jacc.2012.04.063.
   PubMed Web of Science ®Google Scholar
• Guo, Y., Lip, G. Y., & Apostolakis, S. (2015). Inflammatory biomarkers and atrial fibrillation: potential role of inflammatory pathways in the pathogenesis of atrial fibrillation-induced thromboembolism. Current Vascular Pharmacology, 13(2), 192–201. doi: 10.2174/15701611113116660165.
   PubMed Web of Science ®Google Scholar
• Hannestad, J., DellaGioia, N., & Bloch, M. (2011). The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology, 36(12), 2452–2459. doi: 10.1038/npp.2011.132.
   PubMed Web of Science ®Google Scholar
• Hansson, A., Madsen-Härdig, B., & Olsson, S. B. (2004). Arrhythmia-provoking factors and symptoms at the onset of paroxysmal atrial fibrillation: A study based on interviews with 100 patients seeking hospital assistance. BMC Cardiovascular Disorders, 4, 13. doi: 10.1186/1471-2261-4-13.
   PubMedGoogle Scholar
• Harsch, H. H. (1991). Atrial fibrillation, cardioversion, and electroconvulsive therapy. Convuls Ther, 7, 139–142.
   PubMedGoogle Scholar
• Healey, J. S., Baranchuk, A., Crystal, E., Morillo, C. A., Garfinkle, M., Yusuf, S., & Connolly, S. J. (2005). Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: A meta-analysis. Journal of the American College of Cardiology, 45(11), 1832–1839. doi: 10.1016/j.jacc.2004.11.070.
   PubMed Web of Science ®Google Scholar
• Hooker, S. A., O’Connor, P. J., Sperl-Hillen, J. M., Crain, A. L., Ohnsorg, K., Kane, S., & Rossom, R. (2022). Depression and cardiovascular risk in primary care patients. Journal of Psychosomatic Research, 158, 110920. doi: 10.1016/j.jpsychores.2022.110920.
   PubMed Web of Science ®Google Scholar
• Hu, L.-Y., Shen, C.-C., Hu, Y.-W., Chen, M.-H., Tsai, C.-F., Chiang, H.-L., Yeh, C.-M., Wang, W.-S., Chen, P.-M., Hu, T.-M., Chen, T.-J., Su, T.-P., & Liu, C.-J. (2013). Hyperthyroidism and risk for bipolar disorders: A nationwide population-based study. PLOS One, 8(8), e73057. doi: 10.1371/journal.pone.0073057.
   PubMed Web of Science ®Google Scholar
• Huffman, J. C., & Stern, T. A. (2007). Neuropsychiatric consequences of cardiovascular medications. Dialogues in Clinical Neuroscience, 9(1), 29–45. doi: 10.31887/DCNS.2007.9.1/jchuffman.
   PubMedGoogle Scholar
• Ihara, K., & Sasano, T. (2022). Role of inflammation in the pathogenesis of atrial fibrillation. Frontiers in Physiology, 13, 862164. doi: 10.3389/fphys.2022.862164.
   PubMed Web of Science ®Google Scholar
• Ittermann, T., Völzke, H., Baumeister, S. E., Appel, K., & Grabe, H. J. (2015). Diagnosed thyroid disorders are associated with depression and anxiety. Social Psychiatry and Psychiatric Epidemiology, 50(9), 1417–1425. doi: 10.1007/s00127-015-1043-0.
   PubMed Web of Science ®Google Scholar
• Jaakkola, J., Teppo, K., Biancari, F., Halminen, O., Putaala, J., Mustonen, P., Haukka, J., Linna, M., Kinnunen, J., Tiili, P., Aro, A. L., Hartikainen, J., Airaksinen, K. E. J., & Lehto, M. (2022). The effect of mental health conditions on the use of oral anticoagulation therapy in patients with atrial fibrillation: The FinACAF study. European Heart Journal. Quality of Care & Clinical Outcomes, 8(3), 269–276. doi: 10.1093/ehjqcco/qcab077.
   PubMed Web of Science ®Google Scholar
• Jansen, H. J., Mackasey, M., Moghtadaei, M., Belke, D. D., Egom, E. E., Tuomi, J. M., Rafferty, S. A., Kirkby, A. W., & Rose, R. A. (2018). Distinct patterns of atrial electrical and structural remodeling in angiotensin II mediated atrial fibrillation. Journal of Molecular and Cellular Cardiology, 124, 12–25. doi: 10.1016/j.yjmcc.2018.09.011.
   PubMed Web of Science ®Google Scholar
• Jia, S., Hou, Y., Wang, D., & Zhao, X. (2022). Flavonoids for depression and anxiety: a systematic review and meta-analysis. Critical Reviews in Food Science and Nutrition, 1–11. Online ahead of print. doi: 10.1080/10408398.2022.2057914.
   Google Scholar
• Jia, Z., Du, X., Lu, S., Yang, X., Chang, S., Liu, J., Li, J., Zhou, Y., Macle, L., Dong, J., & Ma, C. (2019). Effect of mental health status on arrhythmia recurrence after catheter ablation of atrial fibrillation. The Canadian Journal of Cardiology, 35(7), 831–839. doi: 10.1016/j.cjca.2019.02.007.
   PubMed Web of Science ®Google Scholar
• Kalcik Md, M., Ozan Gursoy Md, M., Keles Md, N., et al. (2014). Acute atrial fibrillation as an unusual form of cardiotoxicity in chronic lithium overdose. J Atr Fibrillation, 6, 1009.
   PubMedGoogle Scholar
• Kang, Y. (2006). Effect of uncertainty on depression in patients with newly diagnosed atrial fibrillation. Progress in Cardiovascular Nursing, 21(2), 83–88. doi: 10.1111/j.0889-7204.2006.04810.x.
   PubMedGoogle Scholar
• Kim, Y. G., Lee, K.-N., Han, K.-D., Han, K.-M., Min, K., Choi, H. Y., Choi, Y. Y., Shim, J., Choi, J.-I., & Kim, Y.-H. (2022). Association of depression with atrial fibrillation in South Korean adults. JAMA Network Open, 5(1), e2141772. doi: 10.1001/jamanetworkopen.2021.41772.
   PubMed Web of Science ®Google Scholar
• Koleck, T. A., Mitha, S. A., Biviano, A., Caceres, B. A., Corwin, E. J., Goldenthal, I., Creber, R. M., Turchioe, M. R., Hickey, K. T., & Bakken, S. (2021). Exploring depressive symptoms and anxiety among patients with atrial fibrillation and/or flutter at the time of cardioversion or ablation. The Journal of Cardiovascular Nursing, 36(5), 470–481. doi: 10.1097/JCN.0000000000000723.
   PubMed Web of Science ®Google Scholar
• Korantzopoulos, P., Letsas, K. P., Tse, G., Fragakis, N., Goudis, C. A., & Liu, T. (2018). Inflammation and atrial fibrillation: A comprehensive review. Journal of Arrhythmia, 34(4), 394–401. doi: 10.1002/joa3.12077.
   PubMed Web of Science ®Google Scholar
• Kornelius, E., Chang, K.-L., Yang, Y.-S., Huang, J.-Y., Ku, M.-S., Lee, K.-Y., & Ho, S.-W. (2021). Epidemiology and factors associated with mortality of thyroid storm in Taiwan: a nationwide population-based study. Internal and Emergency Medicine, 16(3), 601–607. doi: 10.1007/s11739-020-02445-6.
   PubMed Web of Science ®Google Scholar
• Kuwano, N., Kato, T. A., Mitsuhashi, M., Sato-Kasai, M., Shimokawa, N., Hayakawa, K., Ohgidani, M., Sagata, N., Kubo, H., Sakurai, T., & Kanba, S. (2018). Neuron-related blood inflammatory markers as an objective evaluation tool for major depressive disorder: An exploratory pilot case-control study. Journal of Affective Disorders, 240, 88–98. doi: 10.1016/j.jad.2018.07.040.
   PubMed Web of Science ®Google Scholar
• Ladwig, K. H., Goette, A., Atasoy, S., & Johar, H. (2020). Psychological aspects of atrial fibrillation: A systematic narrative review: Impact on incidence, cognition, prognosis, and symptom perception. Current Cardiology Reports, 22(11), 137. doi: 10.1007/s11886-020-01396-w.
   PubMed Web of Science ®Google Scholar
• Lakkireddy, D., Atkins, D., Pillarisetti, J., Ryschon, K., Bommana, S., Drisko, J., Vanga, S., & Dawn, B. (2013). Effect of yoga on arrhythmia burden, anxiety, depression, and quality of life in paroxysmal atrial fibrillation: The YOGA my heart study. Journal of the American College of Cardiology, 61(11), 1177–1182. doi: 10.1016/j.jacc.2012.11.060.
   PubMed Web of Science ®Google Scholar
• Lange, H. W., & Herrmann-Lingen, C. (2007). Depressive symptoms predict recurrence of atrial fibrillation after cardioversion. Journal of Psychosomatic Research, 63(5), 509–513. doi: 10.1016/j.jpsychores.2007.07.010.
   PubMed Web of Science ®Google Scholar
• Lapi, F., Azoulay, L., Kezouh, A., Benisty, J., Matok, I., Mugelli, A., & Suissa, S. (2015). The use of antidepressants and the risk of chronic atrial fibrillation. Journal of Clinical Pharmacology, 55(4), 423–430. doi: 10.1002/jcph.435.
   PubMed Web of Science ®Google Scholar
• Leonard, B., & Maes, M. (2012). Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression. Neuroscience and Biobehavioral Reviews, 36(2), 764–785. doi: 10.1016/j.neubiorev.2011.12.005.
   PubMed Web of Science ®Google Scholar
• Lloyd-Jones, D. M., Allen, N. B., Anderson, C. A. M., Black, T., Brewer, L. C., Foraker, R. E., Grandner, M. A., Lavretsky, H., Perak, A. M., Sharma, G., & Rosamond, W., (2022). Life’s essential 8: Updating and enhancing the American Heart Association’s construct of cardiovascular health: A presidential advisory from the American Heart Association. Circulation, 146(5), e18–e43. doi: 10.1161/CIR.0000000000001078.
   PubMed Web of Science ®Google Scholar
• Malouf, J. F., Kanagala, R., Al Atawi, F. O., Rosales, A. G., Davison, D. E., Murali, N. S., Tsang, T. S. M., Chandrasekaran, K., Ammash, N. M., Friedman, P. A., & Somers, V. K. (2005). High sensitivity C-reactive protein: A novel predictor for recurrence of atrial fibrillation after successful cardioversion. Journal of the American College of Cardiology, 46(7), 1284–1287. doi: 10.1016/j.jacc.2005.06.053.
   PubMed Web of Science ®Google Scholar
• Manolis, A. A., Manolis, T. A., Apostolopoulos, E. J., Apostolaki, N. E., Melita, H., & Manolis, A. S. (2021a). The role of the autonomic nervous system in cardiac arrhythmias: The neuro-cardiac axis, more foe than friend? Trends in Cardiovascular Medicine, 31(5), 290–302. doi: 10.1016/j.tcm.2020.04.011.
   PubMed Web of Science ®Google Scholar
• Manolis, A. A., Manolis, T. A., Melita, H., & Manolis, A. S. (2020). Subclinical thyroid dysfunction and cardiovascular consequences: An alarming wake-up call? Trends in Cardiovascular Medicine, 30(2), 57–69. doi: 10.1016/j.tcm.2019.02.011.
   PubMed Web of Science ®Google Scholar
• Manolis, A. S. (2015). Atrial fibrillation and cognitive impairment. Rhythmos, 10, 45–52.
   Google Scholar
• Manolis, A. S., Manolis, T. A., Manolis, A. A., & Melita, H. (2022a). Atrial fibrillation-induced tachycardiomyopathy and heart failure: an underappreciated and elusive condition. Heart Failure Reviews, 27(6), 2119–2135. doi: 10.1007/s10741-022-10221-1.
   PubMed Web of Science ®Google Scholar
• Manolis, T. A., Apostolopoulos, E. J., Manolis, A. A., Melita, H., & Manolis, A. S. (2022b). The proarrhythmic conundrum of alcohol intake. Trends in Cardiovascular Medicine, 32(4), 237–245. doi: 10.1016/j.tcm.2021.03.003.
   PubMed Web of Science ®Google Scholar
• Manolis, T. A., Manolis, A. A., & Manolis, A. S. (2019a). Cardiovascular safety of psychiatric agents: A cautionary tale. Angiology, 70(2), 103–129. doi: 10.1177/0003319718780145.
   PubMed Web of Science ®Google Scholar
• Manolis, T. A., Manolis, A. A., Apostolopoulos, E. J., Melita, H., & Manolis, A. S. (2021b). Cardiovascular complications of sleep disorders: A better night’s sleep for a healthier heart/from bench to bedside. Current Vascular Pharmacology, 19(2), 210–232. doi: 10.2174/1570161118666200325102411.
   PubMed Web of Science ®Google Scholar
• Manolis, T. A., Manolis, A. A., Melita, H., & Manolis, A. S. (2019b). Sudden unexpected death in epilepsy: The neuro-cardio-respiratory connection. Seizure, 64, 65–73. doi: 10.1016/j.seizure.2018.12.007.
   PubMed Web of Science ®Google Scholar
• McCabe, P. J., Barnason, S. A., & Houfek, J. (2011). Illness beliefs in patients with recurrent symptomatic atrial fibrillation. Pacing and Clinical Electrophysiology : PACE, 34(7), 810–820. doi: 10.1111/j.1540-8159.2011.03105.x.
   PubMed Web of Science ®Google Scholar
• Moorehead, C. N., & Knox, S. J. (1965). Imipramine-induced auricular fibrillation. The American Journal of Psychiatry, 122, 216–217. doi: 10.1176/ajp.122.2.216.
   PubMed Web of Science ®Google Scholar
• Nso, N., Bookani, K. R., Metzl, M., & Radparvar, F. (2021). Role of inflammation in atrial fibrillation: A comprehensive review of current knowledge. Journal of Arrhythmia, 37(1), 1–10. doi: 10.1002/joa3.12473.
   PubMed Web of Science ®Google Scholar
• Nunes, F. D. D., Ferezin, L. P., Pereira, S. C., et al. (2022). The Association of biochemical and genetic biomarkers in VEGF pathway with depression. Pharmaceutics, 14, 2757. doi: 10.3390/pharmaceutics14122757.
   PubMed Web of Science ®Google Scholar
• Ogunmoroti, O., Michos, E. D., Aronis, K. N., Salami, J. A., Blankstein, R., Virani, S. S., Spatz, E. S., Allen, N. B., Rana, J. S., Blumenthal, R. S., Veledar, E., Szklo, M., Blaha, M. J., & Nasir, K. (2018). Life’s simple 7 and the risk of atrial fibrillation: The multi-ethnic study of atherosclerosis. Atherosclerosis, 275, 174–181. doi: 10.1016/j.atherosclerosis.2018.05.050.
   PubMed Web of Science ®Google Scholar
• Ong, L., Irvine, J., Nolan, R., Cribbie, R., Harris, L., Newman, D., Mangat, I., & Dorian, P. (2006). Gender differences and quality of life in atrial fibrillation: The mediating role of depression. Journal of Psychosomatic Research, 61(6), 769–774. doi: 10.1016/j.jpsychores.2006.08.003.
   PubMed Web of Science ®Google Scholar
• Pasco, J. A., Jacka, F. N., Williams, L. J., Henry, M. J., Nicholson, G. C., Kotowicz, M. A., & Berk, M. (2010). Clinical implications of the cytokine hypothesis of depression: the association between use of statins and aspirin and the risk of major depression. Psychotherapy and Psychosomatics, 79(5), 323–325. doi: 10.1159/000319530.
   PubMed Web of Science ®Google Scholar
• Pasic, J., Levy, W. C., & Sullivan, M. D. (2003). Cytokines in depression and heart failure. Psychosomatic Medicine, 65(2), 181–193. doi: 10.1097/01.psy.0000058372.50240.38.
   PubMed Web of Science ®Google Scholar
• Patel, D., Mc Conkey, N. D., Sohaney, R., Mc Neil, A., Jedrzejczyk, A., & Armaganijan, L. (2013). A systematic review of depression and anxiety in patients with atrial fibrillation: The mind-heart link. Cardiovascular Psychiatry and Neurology, 2013, 159850. doi: 10.1155/2013/159850.
   PubMedGoogle Scholar
• Patten, S. B., & Love, E. J. (1997). Drug-induced depression. Psychotherapy and Psychosomatics, 66(2), 63–73. doi: 10.1159/000289110.
   PubMed Web of Science ®Google Scholar
• Patterson, S. L., Marcus, M., Goetz, M., Vaccarino, V., & Gooding, H. C. (2022). Depression and anxiety are associated with cardiovascular health in young adults. Journal of the American Heart Association., 11, e027610. doi: 10.1161/JAHA.122.027610.
   PubMed Web of Science ®Google Scholar
• Pavlicek, V., Wedegärtner, S. M., Millenaar, D., Wintrich, J., Böhm, M., Kindermann, I., & Ukena, C. (2022). Heart-focused anxiety, general anxiety, depression and health-related quality of life in patients with atrial fibrillation undergoing pulmonary vein isolation. Journal of Clinical Medicine, 11(7), 11.
   Web of Science ®Google Scholar
• Perret-Guillaume, C., Briancon, S., Wahl, D., Guillemin, F., & Empereur, F. (2010). Quality of life in elderly inpatients with atrial fibrillation as compared with controlled subjects. The Journal of Nutrition, Health & Aging, 14(2), 161–166. doi: 10.1007/s12603-009-0188-5.
   PubMed Web of Science ®Google Scholar
• Petrides, G., & Fink, M. (1996). Atrial fibrillation, anticoagulation, and electroconvulsive therapy. Convulsive Therapy, 12(2), 91–98.
   PubMedGoogle Scholar
• Polikandrioti, M., Koutelekos, I., Vasilopoulos, G., Gerogianni, G., Gourni, M., Zyga, S., & Panoutsopoulos, G. (2018). Anxiety and depression in patients with permanent atrial fibrillation: prevalence and associated factors. Cardiology Research and Practice, 2018, 7408129. doi: 10.1155/2018/7408129.
   PubMed Web of Science ®Google Scholar
• Portnoi, V. A. (1980). T3 toxicosis presented by depression in an elderly woman. Postgraduate Medical Journal, 56(657), 509–510. doi: 10.1136/pgmj.56.657.509.
   PubMed Web of Science ®Google Scholar
• Remick, R. A., & Froese, C. (1989). Unnecessary delay in tricyclic antidepressant treatment of a patient with atrial fibrillation. Can Fam Physician, 35, 1101–1102.
   PubMed Web of Science ®Google Scholar
• Rimón, R., Le Grevés, P., Nyberg, F., Heikkilä, L., Salmela, L., & Terenius, L. (1984). Elevation of substance P-like peptides in the CSF of psychiatric patients. Biological Psychiatry., 19, 509–516.
   PubMed Web of Science ®Google Scholar
• Risom, S. S., Thygesen, L. C., Rasmussen, T. B., Borregaard, B., Nørgaard, M. W., Mols, R., Christensen, A. V., Thorup, C. B., Thrysoee, L., Juel, K., Ekholm, O., & Berg, S. K. (2023). Association between risk factors and readmission for patients with atrial fibrillation treated with catheter ablation: Results from the Nationwide DenHeart study. The Journal of Cardiovascular Nursing, 38(1), E31–E39. doi: 10.1097/JCN.0000000000000900.
   PubMed Web of Science ®Google Scholar
• Rizzi, S. A., Knight, S., May, H. T., Woller, S. C., Stevens, S. M., Steinberg, B. A., Bair, T. L., Anderson, J. L., Muhlestein, J. B., Knowlton, K. U., & Bunch, T. J. (2021). Depression as a driving force for low time in therapeutic range and dementia in patients with and without atrial fibrillation. The American Journal of Cardiology, 153, 58–64. doi: 10.1016/j.amjcard.2021.05.021.
   PubMed Web of Science ®Google Scholar
• Rommel, J., Simpson, R., Mounsey, J. P., Chung, E., Schwartz, J., Pursell, I., & Gehi, A. (2013). Effect of body mass index, physical activity, depression, and educational attainment on high-sensitivity C-reactive protein in patients with atrial fibrillation. The American Journal of Cardiology, 111(2), 208–212. doi: 10.1016/j.amjcard.2012.09.017.
   PubMed Web of Science ®Google Scholar
• Saab, Y. B., Gard, P. R., Yeoman, M. S., Mfarrej, B., El-Moalem, H., & Ingram, M. J. (2007). Renin-angiotensin-system gene polymorphisms and depression. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 31(5), 1113–1118. doi: 10.1016/j.pnpbp.2007.04.002.
   PubMed Web of Science ®Google Scholar
• Sang, C.-H., Chen, K., Pang, X.-F., Dong, J.-Z., Du, X., Ma, H., Liu, J.-H., Ma, C.-S., & Sun, Y.-X. (2013). Depression, anxiety, and quality of life after catheter ablation in patients with paroxysmal atrial fibrillation. Clinical Cardiology, 36(1), 40–45. doi: 10.1002/clc.22039.
   PubMed Web of Science ®Google Scholar
• Schnabel, R. B., Michal, M., Wilde, S., Wiltink, J., Wild, P. S., Sinning, C. R., Lubos, E., Ojeda, F. M., Zeller, T., Munzel, T., Blankenberg, S., & Beutel, M. E. (2013). Depression in atrial fibrillation in the general population. PLOS One, 8(12), e79109. doi: 10.1371/journal.pone.0079109.
   PubMed Web of Science ®Google Scholar
• Schneider, M. P., Hua, T. A., Böhm, M., Wachtell, K., Kjeldsen, S. E., & Schmieder, R. E. (2010). Prevention of atrial fibrillation by renin-angiotensin system inhibition a meta-analysis. Journal of the American College of Cardiology, 55(21), 2299–2307. doi: 10.1016/j.jacc.2010.01.043.
   PubMed Web of Science ®Google Scholar
• Seaburg, L., Hess, E. P., Coylewright, M., Ting, H. H., McLeod, C. J., & Montori, V. M. (2014). Shared decision making in atrial fibrillation: Where we are and where we should be going. Circulation, 129(6), 704–710. doi: 10.1161/CIRCULATIONAHA.113.004498.
   PubMed Web of Science ®Google Scholar
• Sears, S. F., Anthony, S., Harrell, R., Tripp, C., Bowman, J., Khan, S., & Naniwadekar, A. (2022). Managing atrial fibrillation: the intersection of cardiology, health psychology, and the patient experience. Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association, 41(10), 792–802. doi: 10.1037/hea0001135.
   PubMed Web of Science ®Google Scholar
• Sharma, G., Mooventhan, A., Naik, G., & Nivethitha, L. (2021). A review on role of Yoga in the management of patients with cardiac arrhythmias. International Journal of Yoga, 14(1), 26–35. doi: 10.4103/ijoy.IJOY_7_20.
   PubMedGoogle Scholar
• Shiga, T. (2022). Depression and cardiovascular diseases. J Cardiol, S0914-5087(22), 00281–00287. doi: 10.1016/j.jjcc.2022.11.010.
   Google Scholar
• Shirayama, T., Sakamoto, T., Sakatani, T., Mani, H., Yamamoto, T., & Matsubara, H. (2006). Usefulness of paroxetine in depressed men with paroxysmal atrial fibrillation. The American Journal of Cardiology, 97(12), 1749–1751. doi: 10.1016/j.amjcard.2006.01.038.
   PubMed Web of Science ®Google Scholar
• Smaardijk, V. R., Maas, A., Lodder, P., Kop, W. J., & Mommersteeg, P. M. C. (2020). Sex and gender-stratified risks of psychological factors for adverse clinical outcomes in patients with ischemic heart disease: A systematic review and meta-analysis. International Journal of Cardiology, 302, 21–29. doi: 10.1016/j.ijcard.2019.12.014.
   PubMed Web of Science ®Google Scholar
• Spier, S. A., & Frontera, M. A. (1991). Unexpected deaths in depressed medical inpatients treated with fluoxetine. J Clin Psychiatry, 52, 377–382.
   PubMed Web of Science ®Google Scholar
• Taylor, E. C., O’Neill, M., Hughes, L. D., & Moss-Morris, R. (2022). Atrial fibrillation, quality of life and distress: a cluster analysis of cognitive and behavioural responses. Quality of Life Research : An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation, 31(5), 1415–1425. doi: 10.1007/s11136-021-03006-w.
   PubMed Web of Science ®Google Scholar
• Teppo, K., Jaakkola, J., Airaksinen, K. E. J., Biancari, F., Halminen, O., Putaala, J., Mustonen, P., Haukka, J., Hartikainen, J., Luojus, A., Niemi, M., Linna, M., & Lehto, M. (2022). Mental health conditions and adherence to direct oral anticoagulants in patients with incident atrial fibrillation: A nationwide cohort study. General Hospital Psychiatry, 74, 88–93. doi: 10.1016/j.genhosppsych.2021.12.012.
   PubMed Web of Science ®Google Scholar
• Teppo, K., Jaakkola, J., Airaksinen, K. E. J., et al. (2022). Mental health conditions and nonpersistence of direct oral anticoagulant use in patients with incident atrial fibrillation: A nationwide cohort study. Journal of the American Heart Association., 11, e024119. doi: 10.1161/JAHA.121.024119.
   PubMed Web of Science ®Google Scholar
• Teppo, K., Jaakkola, J., Biancari, F., Halminen, O., Putaala, J., Mustonen, P., Haukka, J., Linna, M., Kinnunen, J., Luojus, A., Itäinen-Strömberg, S., Penttilä, T., Niemi, M., Hartikainen, J., Airaksinen, K. J., & Lehto, M. (2022). Mental health conditions and use of rhythm control therapies in patients with atrial fibrillation: A nationwide cohort study. BMJ Open, 12(8), e059759. doi: 10.1136/bmjopen-2021-059759.
   PubMed Web of Science ®Google Scholar
• Teppo, K., Jaakkola, J., Lehto, M., Biancari, F., & Airaksinen, K. E. J. (2021). The impact of mental health conditions on oral anticoagulation therapy and outcomes in patients with atrial fibrillation: A systematic review and meta-analysis. American Journal of Preventive Cardiology, 7, 100221. doi: 10.1016/j.ajpc.2021.100221.
   PubMedGoogle Scholar
• Thomas, F. B., Mazzaferri, E. L., & Skillman, T. G. (1970). Apathetic thyrotoxicosis: A distinctive clinical and laboratory entity. Annals of Internal Medicine, 72(5), 679–685. doi: 10.7326/0003-4819-72-5-679.
   PubMed Web of Science ®Google Scholar
• Thrall, G., Lip, G. Y., Carroll, D., & Lane, D. (2007). Depression, anxiety, and quality of life in patients with atrial fibrillation. Chest, 132(4), 1259–1264. doi: 10.1378/chest.07-0036.
   PubMed Web of Science ®Google Scholar
• Trovato, G. M., Pace, P., Cangemi, E., Martines, G. F., Trovato, F. M., & Catalano, D. (2012). Gender, lifestyles, illness perception and stress in stable atrial fibrillation. Clin Ter, 163, 281–286.
   PubMed Web of Science ®Google Scholar
• Turker, Y., Ekinozu, I., Aytekin, S., Turker, Y., Basar, C., Baltaci, D., & Kaya, E. (2017). Comparison of changes in anxiety and depression level between dabigatran and warfarin use in patients with atrial fibrillation. Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 23(2), 164–167. doi: 10.1177/1076029615600792.
   PubMed Web of Science ®Google Scholar
• Varghese, B., Feldman, D. I., Chew, C., Valilis, E., Blumenthal, R. S., Sharma, G., & Calkins, H. (2021). Inflammation, atrial fibrillation, and the potential role for colchicine therapy. Heart Rhythm O2, 2(3), 298–303. doi: 10.1016/j.hroo.2021.03.011.
   PubMedGoogle Scholar
• Vian, J., Pereira, C., Chavarria, V., Köhler, C., Stubbs, B., Quevedo, J., Kim, S.-W., Carvalho, A. F., Berk, M., & Fernandes, B. S. (2017). The renin-angiotensin system: A possible new target for depression. BMC Medicine, 15(1), 144. doi: 10.1186/s12916-017-0916-3.
   PubMedGoogle Scholar
• von Eisenhart Rothe, A. F., Goette, A., Kirchhof, P., Breithardt, G., Limbourg, T., Calvert, M., Baumert, J., & Ladwig, K.-H. (2014). Depression in paroxysmal and persistent atrial fibrillation patients: A cross-sectional comparison of patients enroled in two large clinical trials. Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology, 16(6), 812–819. doi: 10.1093/europace/eut361.
   PubMed Web of Science ®Google Scholar
• von Eisenhart Rothe, A., Hutt, F., Baumert, J., Breithardt, G., Goette, A., Kirchhof, P., & Ladwig, K.-H. (2015). Depressed mood amplifies heart-related symptoms in persistent and paroxysmal atrial fibrillation patients: A longitudinal analysis–data from the German competence network on atrial fibrillation. Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology, 17(9), 1354–1362. doi: 10.1093/europace/euv018.
   PubMed Web of Science ®Google Scholar
• Wachtell, K., Lehto, M., Gerdts, E., Olsen, M. H., Hornestam, B., Dahlöf, B., Ibsen, H., Julius, S., Kjeldsen, S. E., Lindholm, L. H., Nieminen, M. S., & Devereux, R. B. (2005). Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: The Losartan intervention for end point reduction in hypertension (LIFE) study. Journal of the American College of Cardiology, 45(5), 712–719. doi: 10.1016/j.jacc.2004.10.068.
   PubMed Web of Science ®Google Scholar
• Walters, T. E., Wick, K., Tan, G., et al. (2018). Psychological distress and suicidal ideation in patients with atrial fibrillation: Prevalence and response to management strategy. Journal of the American Heart Association., 7, e005502. doi: 10.1161/JAHA.117.005502.
   PubMed Web of Science ®Google Scholar
• Wang, Y., Zhao, X., O’Neil, A., Turner, A., Liu, X., & Berk, M. (2013). Altered cardiac autonomic nervous function in depression. BMC Psychiatry, 13, 187. doi: 10.1186/1471-244X-13-187.
   PubMed Web of Science ®Google Scholar
• Whang, W., Davidson, K. W., Conen, D., Tedrow, U. B., Everett, B. M., & Albert, C. M. (2012). Global psychological distress and risk of atrial fibrillation among women: The Women’s health study. Journal of the American Heart Association, 1(3), e001107. doi: 10.1161/JAHA.112.001107.
   PubMed Web of Science ®Google Scholar
• Yang, H. Y., Huang, J. H., Lin, Y. K., Hsu, C. Y., Chen, S. A., & Chen, Y. J. (2014). Bipolar disorder and schizophrenia present different risks of atrial fibrillation: A nationwide population-based analysis. Acta Cardiol Sin, 30, 46–52.
   PubMed Web of Science ®Google Scholar
• Yu, S., Zhao, Q., Wu, P., Qin, M., Huang, H., Cui, H., & Huang, C. (2012). Effect of anxiety and depression on the recurrence of paroxysmal atrial fibrillation after circumferential pulmonary vein ablation. Journal of Cardiovascular Electrophysiology, 23 Suppl 1, S17–S23. doi: 10.1111/j.1540-8167.2012.02436.x.
   PubMed Web of Science ®Google Scholar
• Yu, S-b., Hu, W., Zhao, Q-y., Qin, M., Huang, H., Cui, H-y., & Huang, C-x. (2012). Effect of anxiety and depression on the recurrence of persistent atrial fibrillation after circumferential pulmonary vein ablation. Chinese Medical Journal, 125(24), 4368–4372.
   PubMed Web of Science ®Google Scholar
• Zhang, F., Cao, H., & Baranova, A. (2021). Shared genetic liability and causal associations between major depressive disorder and cardiovascular diseases. Frontiers in Cardiovascular Medicine, 8, 735136. doi: 10.3389/fcvm.2021.735136.
   PubMed Web of Science ®Google Scholar
• Zhang, L., Bao, Y., Tao, S., Zhao, Y., & Liu, M. (2022). The association between cardiovascular drugs and depression/anxiety in patients with cardiovascular disease: A meta-analysis. Pharmacological Research, 175, 106024. doi: 10.1016/j.phrs.2021.106024.
   PubMed Web of Science ®Google Scholar
• Zhuo, C., Ji, F., Lin, X., Jiang, D., Wang, L., Tian, H., Xu, Y., Liu, S., & Chen, C. (2020). Depression and recurrence of atrial fibrillation after catheter ablation: a meta-analysis of cohort studies. Journal of Affective Disorders, 271, 27–32. doi: 10.1016/j.jad.2020.03.118.
   PubMed Web of Science ®Google Scholar